PMID- 10364160 OWN - NLM STAT- MEDLINE DCOM- 19990727 LR - 20211203 IS - 0890-9369 (Print) IS - 0890-9369 (Linking) VI - 13 IP - 11 DP - 1999 Jun 1 TI - A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. PG - 1438-52 AB - An insulin receptor-like signaling pathway regulates Caenorhabditis elegans metabolism, development, and longevity. Inactivation of the insulin receptor homolog DAF-2, the AGE-1 PI3K, or the AKT-1 and AKT-2 kinases causes a developmental arrest at the dauer stage. A null mutation in the daf-16 Fork head transcription factor alleviates the requirement for signaling through this pathway. We show here that a loss-of-function mutation in pdk-1, the C. elegans homolog of the mammalian Akt/PKB kinase PDK1, results in constitutive arrest at the dauer stage and increased life span; these phenotypes are suppressed by a loss of function mutation in daf-16. An activating mutation in pdk-1 or overexpression of wild-type pdk-1 relieves the requirement for AGE-1 PI3K signaling. Therefore, pdk-1 activity is both necessary and sufficient to propagate AGE-1 PI3K signals in the DAF-2 insulin receptor-like signaling pathway. The activating mutation in pdk-1 requires akt-1 and akt-2 gene activity in order to suppress the dauer arrest phenotype of age-1. This indicates that the major function of C. elegans PDK1 is to transduce signals from AGE-1 to AKT-1 and AKT-2. The activating pdk-1 mutation is located in a conserved region of the kinase domain; the equivalent amino acid substitution in human PDK1 activates its kinase activity toward mammalian Akt/PKB. FAU - Paradis, S AU - Paradis S AD - Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard Medical School, Boston, Massachusetts 02114, USA. FAU - Ailion, M AU - Ailion M FAU - Toker, A AU - Toker A FAU - Thomas, J H AU - Thomas JH FAU - Ruvkun, G AU - Ruvkun G LA - eng SI - GENBANK/AF130406 SI - GENBANK/AF130407 GR - R01 AG014161/AG/NIA NIH HHS/United States GR - R01 CA075134/CA/NCI NIH HHS/United States GR - R01AG14161/AG/NIA NIH HHS/United States GR - R01CA75134/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Genes Dev JT - Genes & development JID - 8711660 RN - 0 (Caenorhabditis elegans Proteins) RN - 0 (Helminth Proteins) RN - 0 (Luminescent Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 147336-22-9 (Green Fluorescent Proteins) RN - EC 2.7.1.137 (AGE-1 protein, C elegans) RN - EC 2.7.10.1 (DAF-2 protein, C elegans) RN - EC 2.7.10.1 (Receptor, Insulin) RN - EC 2.7.11.1 (3-Phosphoinositide-Dependent Protein Kinases) RN - EC 2.7.11.1 (AKT1 protein, human) RN - EC 2.7.11.1 (AKT2 protein, human) RN - EC 2.7.11.1 (PDPK1 protein, human) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (akt-1 protein, C elegans) RN - EC 2.7.11.1 (akt-2 protein, C elegans) RN - HG18B9YRS7 (Valine) RN - OF5P57N2ZX (Alanine) SB - IM MH - 3-Phosphoinositide-Dependent Protein Kinases MH - Alanine MH - Alleles MH - Amino Acid Sequence MH - Animals MH - Caenorhabditis elegans/*enzymology/genetics/*physiology MH - *Caenorhabditis elegans Proteins MH - Enzyme Activation MH - Gene Expression Regulation, Enzymologic MH - Green Fluorescent Proteins MH - Helminth Proteins/*metabolism MH - Humans MH - Luminescent Proteins/genetics MH - Molecular Sequence Data MH - Mutagenesis MH - Phenotype MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Protein Serine-Threonine Kinases/genetics/*metabolism MH - Proto-Oncogene Proteins/genetics MH - Proto-Oncogene Proteins c-akt MH - Receptor, Insulin/genetics/metabolism MH - Sequence Homology, Amino Acid MH - *Signal Transduction MH - Valine PMC - PMC316759 EDAT- 1999/06/11 00:00 MHDA- 1999/06/11 00:01 CRDT- 1999/06/11 00:00 PHST- 1999/06/11 00:00 [pubmed] PHST- 1999/06/11 00:01 [medline] PHST- 1999/06/11 00:00 [entrez] AID - 10.1101/gad.13.11.1438 [doi] PST - ppublish SO - Genes Dev. 1999 Jun 1;13(11):1438-52. doi: 10.1101/gad.13.11.1438.